Development of dual acting selenium-doped hydroxyapatite nanoparticles with platinum-bisphosphonate complexes for bone cancer therapy
RSC Advances · 2026 · 16 (11) · 10100-10112
DOI: 10.1039/d5ra09348a ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Alessandra Barbanente und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Bari Aldo Moro via E. Orabona 4 70126 Bari Italy nicola.margiotta@uniba.it. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: European Commission.
Abstract (Originalsprache)
PtBP-HASe nanoparticles represent a promising dual-action biomaterial for bone-targeted cancer therapy. ROS contribute to the antiproliferative activity of both the Pt complexes and the Se-functionalized nanoparticles.
Autor:innen und Institutionen
- Department of Chemistry, University of Bari Aldo Moro via E. Orabona 4 70126 Bari Italy nicola.margiotta@uniba.it.
- Institute for Chemical and Physical Processes (IPCF)-CNR SS Bari via Orabona 4 Bari 70126 Italy.
- National Interuniversity Consortium of Materials Science and Technology (INSTM), Bari Research Unit 70126 Bari Italy.
- Institute of Polymers, Composites and Biomaterials (IPCB)-CNR via Campi Flegrei 34 80078 Pozzuoli Naples Italy.
- Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento 73100 Lecce Italy.
- Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro via Orabona 4 70126 Bari Italy.
ORCID-Profile: Nicoletta Depalo, Roberto Comparelli, Elisabetta Fanizza, Paride Papadia, Concetta Pacifico, Nicola Margiotta
Förderung
- European Commission
Zitieren
APA
Barbanente, A., Di Cosola, A. M., Rizzi, F., Depalo, N., Comparelli, R., Castaldo, R., Fanizza, E., Papadia, P., Pacifico, C., Niso, M., & Margiotta, N. (2026). Development of dual acting selenium-doped hydroxyapatite nanoparticles with platinum-bisphosphonate complexes for bone cancer therapy. RSC Advances, 16(11), 10100-10112. https://doi.org/10.1039/d5ra09348a
Vancouver
Barbanente A, Di Cosola AM, Rizzi F, Depalo N, Comparelli R, Castaldo R, et al. Development of dual acting selenium-doped hydroxyapatite nanoparticles with platinum-bisphosphonate complexes for bone cancer therapy. RSC Advances. 2026;16(11):10100-10112. doi:10.1039/d5ra09348a
BibTeX
@article{Barbanente2026,
author = {Barbanente, Alessandra and Di Cosola, Anna Maria and Rizzi, Federica and Depalo, Nicoletta and Comparelli, Roberto and Castaldo, Rachele and Fanizza, Elisabetta and Papadia, Paride and Pacifico, Concetta and Niso, Mauro and Margiotta, Nicola},
title = {Development of dual acting selenium-doped hydroxyapatite nanoparticles with platinum-bisphosphonate complexes for bone cancer therapy},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {11},
pages = {10100--10112},
doi = {10.1039/d5ra09348a}
}
EUVIMED